Literature DB >> 539151

[Pre-exposure rabies vaccination].

M Stransky.   

Abstract

Prophylactic vaccinations against rabies were given to 150 occupationally exposed persons. A new killed vaccine, grown on human diploid cells, was used. The first immunization resulted in a rapid development of neutralizing antibodies. Antibodies declined very quickly so that 50% of the probands failed to show adequate titres after 12 months. All probands reacted with a distinct rise in antibodies on re-vaccination. The vaccine was well tolerated and local or general reactions were observed only rarely.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 539151     DOI: 10.1007/BF02081339

Source DB:  PubMed          Journal:  Soz Praventivmed        ISSN: 0303-8408


  2 in total

1.  Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum.

Authors:  M Bahmanyar; A Fayaz; S Nour-Salehi; M Mohammadi; H Koprowski
Journal:  JAMA       Date:  1976-12-13       Impact factor: 56.272

2.  Serovaccination by human immune globulin and HDCS-vaccine against rabies.

Authors:  E K Kuwert; J Werner; I Marcus; V J Cabasso
Journal:  Dev Biol Stand       Date:  1978
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.